Developing a European research network to address unmet needs in anxiety disorders

► Anxiety disorders have a 1-year prevalence of 14% and affect over 69 million people in the EU. ► They are distressing, impairing and costly and represent a major public health issue. ► There is much scope for improved recognition and treatment of anxiety disorders. ► Uncertain causes of anxiety disorders hinder the development of refined treatments. ► There is a need for research in more widely representative patient groups.